Blame the medical device tax and the U.S. regulatory environment for the slump in investment in early-stage medical technologies, Silicon Valley Bank's Ben Johnson tells MassDevice.com.
It's a hard world out there for those looking to turn their cutting edge medical device ideas into commercial products, with investors shying away from early-stage companies in favor of more established medtech enterprises.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1vcjzEb
Cap comentari:
Publica un comentari a l'entrada